NCT05706974 Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials Status NOT_YET_RECRUITING Phase N/A
NCT05662488 FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy Status UNKNOWN Phase N/A
NCT05519319 Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma Status RECRUITING Phase NA
NCT05346484 A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05286814 PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma Status RECRUITING Phase PHASE2
NCT05277766 Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer Status RECRUITING Phase PHASE1
NCT05266300 Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. Status COMPLETED Phase N/A
NCT05000294 Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types Status SUSPENDED Phase PHASE1/PHASE2
NCT04993131 Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma Status RECRUITING Phase NA
NCT04937322 Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry. Status COMPLETED Phase N/A
NCT04907643 Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes Status RECRUITING Phase NA
NCT04853017 A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors Status COMPLETED Phase PHASE1
NCT04763642 The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone Status COMPLETED Phase NA
NCT04660929 CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04566133 Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). Status TERMINATED Phase PHASE2